References
- Griffin DE, Pan C-H. Measles: old vaccines and new vaccines. In: Measles - Pathogenesis and Control. Griffin DE, Oldstone MBA (Eds). Springer Verlag, Heidelberg, Germany, 191–212 (2009).
- Gans H, Yasukawa L, Rinki M et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J. Infect. Dis.184, 817–826 (2001).
- Permar SR, Klumpp SA, Mansfield KG et al. Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J. Virol.77, 4396–4400 (2003).
- Pueschel K, Tietz A, Carsillo M, Steward M, Niewiesk S. Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance. J. Virol.81(16), 8571–8578 (2007).
- Katz M. Clinical spectrum of measles. In: Measles Virus. Billeter M, ter Meulen V (Eds). Springer, Berlin, Germany, 1–12 (1995).
- Aaby P, Jensen T, Hansen H. Trial of high dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet2, 809–811 (1988).
- Whittle H, Hanlon P, O’Neil K, Hanlon L, Marsh V, Jupp E. Trial of high-dose Edmonston-Zagreb measles vaccine in Gambia: antibody response and side-effects. Lancet2, 811–814 (1988).
- Garenne M, Leroy O, Beau J, Sene I. Child mortality after high titer measles vaccine: prospective study in Senegal. Lancet338, 903–907 (1991).
- Halsey N. Increased mortality following high titer measles vaccines: too much of a good thing. J. Pediatr. Infect. Dis.12, 462–465 (1993).
- Seng R, Samb B, Simondon F et al. Increased long term mortality associated with rash after early measles vaccination in rural Senegal. Pediatr. Infect. Dis. J.18, 48–52 (1999).
- Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. J. Am. Med. Assoc.280, 527–532 (1998).
- Johnson CE, Darbari A, Darbari DS et al. Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants. Vaccine18, 2411–2415 (2000).
- Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine21, 3398–3405 (2003).
- Siegrist C. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine21, 3406–3412 (2003).
- Heyman B. Functions of antibodies in the regulation of B cell responses in vivo. Springer Semin. Immunopathol.23, 421–432 (2001).
- Niewiesk S. Current animal models: cotton rat. In: Measles - Pathogenesis and Control. Griffin DE, Oldstone MBA (Eds). Springer Verlag, Heidelberg, Germany, 89–110 (2009).
- Kim D, Huey D, Oglesbee M, Niewiesk S. Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood117, 6143–6151 (2011).
- Kim D, Maritinez-Sobrido L, Choi C et al. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies. J. Virol.85, 200–207 (2011).